Back to Search
Start Over
Optimal Duration of MRI Follow-up to Safely Identify Middle Ear Residual Cholesteatoma
- Source :
- AJNR Am J Neuroradiol, American Journal of Neuroradiology, American Journal of Neuroradiology, 2021, 42 (7), pp.1313-1319. ⟨10.3174/ajnr.A7116⟩
- Publication Year :
- 2021
- Publisher :
- American Society of Neuroradiology, 2021.
-
Abstract
- International audience; Background and purpose: Previous studies have demonstrated the usefulness of non-EPI DWI for detection of residual cholesteatoma. However, limited data are available to determine the suitable duration of imaging follow-up after a first MR imaging with normal findings has been obtained. The present study aimed to determine the optimal duration of non-EPI DWI follow-up for residual cholesteatoma.Materials and methods: A retrospective, monocentric study was performed between 2013 and 2019 and included all participants followed up after canal wall up tympanoplasty with at least 2 non-EPI DWI examinations performed on the same 1.5T MR imaging scanner. MR images were reviewed independently by 2 radiologists. Sensitivity and specificity values were calculated as a function of time after the operation. Receiver operating characteristic curves were analyzed to determine the optimal follow-up duration.Results: We analyzed 47 MRIs from 17 participants. At the end of the individual follow-up period, a residual cholesteatoma had been found in 41.1% of cases. The follow-up duration ranged from 20 to 198 months (mean, 65.9 [SD, 43.9] months). Participants underwent between 2 and 5 non-EPI DWI examinations. Analyses of the receiver operating characteristic curves revealed that the optimal diagnostic value of non-EPI DWI occurred 56 months after the operation when the first MR imaging performed a mean of 17.3 (SD, 6.8) months after the operation had normal findings (sensitivity = 0.71; specificity = 0.7, Youden index = 0.43).Conclusions: Repeat non-EPI DWI is required to detect slow-growing middle ear residual cholesteatomas. We, therefore, recommend performing non-EPI DWI for at least the first 5 years after the initial operation.
- Subjects :
- Male
[SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imaging
medicine.medical_treatment
Youden's J statistic
Residual
MESH: Magnetic Resonance Imaging
030218 nuclear medicine & medical imaging
0302 clinical medicine
MESH: Child
Medicine
Child
MESH: Aged
MESH: Middle Aged
Cholesteatoma, Middle Ear
Cholesteatoma
MESH: Follow-Up Studies
Middle Aged
Magnetic Resonance Imaging
medicine.anatomical_structure
MESH: Young Adult
[SDV.MHEP.OS] Life Sciences [q-bio]/Human health and pathology/Sensory Organs
Middle ear
[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]
Female
Adult
Adolescent
Ear, Middle
MESH: Diffusion Magnetic Resonance Imaging
MESH: Ear, Middle
Sensitivity and Specificity
MESH: Cholesteatoma, Middle Ear
03 medical and health sciences
Young Adult
Humans
Radiology, Nuclear Medicine and imaging
[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]
[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory Organs
Head & Neck
Aged
Retrospective Studies
MESH: Adolescent
MESH: Humans
Receiver operating characteristic
business.industry
Canal wall up
MESH: Adult
MESH: Retrospective Studies
Tympanoplasty
medicine.disease
Mr imaging
MESH: Sensitivity and Specificity
MESH: Male
[SDV.IB.IMA] Life Sciences [q-bio]/Bioengineering/Imaging
Diffusion Magnetic Resonance Imaging
Neurology (clinical)
business
Nuclear medicine
MESH: Female
030217 neurology & neurosurgery
Follow-Up Studies
Subjects
Details
- Language :
- English
- ISSN :
- 01956108 and 1936959X
- Database :
- OpenAIRE
- Journal :
- AJNR Am J Neuroradiol, American Journal of Neuroradiology, American Journal of Neuroradiology, 2021, 42 (7), pp.1313-1319. ⟨10.3174/ajnr.A7116⟩
- Accession number :
- edsair.doi.dedup.....4f883e91f970b7ae7c96548aa35bf119
- Full Text :
- https://doi.org/10.3174/ajnr.A7116⟩